Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
NCT02000687 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2026-03-23
Summary
This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.
Conditions
- Type 1 Diabetes Mellitus
Sponsors & Collaborators
-
Rodolfo Alejandro
lead OTHER
Principal Investigators
-
Rodolfo Alejandro, MD · University of Miami
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2027-12-31
- Completion
- 2028-07-31
Countries
- United States
Study Locations
More Related Trials
-
Islet Transplantation for Patients With Type 1 Diabetes
NCT00073281 ·Status: COMPLETED ·Phase: PHASE1
-
Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes
NCT00708604 ·Status: COMPLETED ·Phase: PHASE1
-
Allogeneic Islet Cells Transplanted Onto the Omentum
NCT02213003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Strategies to Improve Islet Survival
NCT00464555 ·Status: COMPLETED ·Phase: PHASE2
-
Islet Transplantation in Type 1 Diabetic Kidney Allograft
NCT01241864 ·Status: RECRUITING ·Phase: PHASE2
-
Islet Transplantation for Type 1 Diabetes Mellitus
NCT00437398 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen
NCT00706420 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression
NCT00021788 ·Status: COMPLETED ·Phase: PHASE2
-
Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen
NCT00021801 ·Status: COMPLETED ·Phase: PHASE2
-
Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
NCT00006505 ·Status: COMPLETED ·Phase: PHASE2
-
Extended Follow-Up After Islet Transplantation in T1D
NCT01369082 ·Status: COMPLETED
-
Nephrologic Prognosis 10 Years After Diabetes Cell Therapy
NCT02627690 ·Status: COMPLETED
-
Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation
NCT01967186 ·Status: UNKNOWN ·Phase: NA
-
Islet Cell Transplants for Diabetes
NCT00303134 ·Status: TERMINATED ·Phase: PHASE1
-
Pancreatic Islet Cell Transplantation
NCT00214786 ·Status: COMPLETED ·Phase: PHASE1
-
Islet Allotransplantation for Type 1 Diabetic Patients
NCT03259256 ·Status: UNKNOWN ·Phase: PHASE3
-
Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus
NCT00315614 ·Status: TERMINATED ·Phase: PHASE2
-
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
NCT00286624 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Islet Allotransplantation With Steroid Free Immunosuppression
NCT00446264 ·Status: COMPLETED ·Phase: PHASE2
-
Islet Transplant Alone in OMENtum
NCT02803905 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Energy Balance Following Islet Transplantation
NCT03063229 ·Status: TERMINATED ·Phase: NA
-
Pancreatic Islet Transplantation to the Anterior Chamber of the Eye
NCT04198350 ·Status: WITHDRAWN ·Phase: NA
-
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
NCT03746769 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Islet Transplant in Patients With Type I Diabetes
NCT03698396 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Infusion of Autologous T Regulatory Cells (T Reg) at the Time of Transplantation of Allogenic Islets of Langerhans
NCT04820270 ·Status: UNKNOWN ·Phase: NA